#BREAKING: Democrats demand Barr, Sessions testify on Apple data subpoenas https://t.co/6Fg4EN6cGC pic.twitter.com/SMKS7ADSr4
— The Hill (@thehill) June 11, 2021
uniQure Announces Update On Low-Dose Cohort In Phase I/II Clinical Trial Of AMT-130 Gene Therapy For The Treatment Of Huntington’s Disease
~ Treatment generally well-tolerated with no significant safety issues related to AMT-130 in treated patients through one year of follow-up ~
~ A mean reduction of 53.8% of mutant HTT (mHTT) observed in
